Biomaterial Database

Radionuclide imaging and therapy of bone metastases in the era of targeted therapy. 2019

Tim Van den Wyngaert, and Frédéric Paycha

Department of Nuclear Medicine, University Hospital of Antwerp, Edegem, Belgium - tim.van.den.wyngaert@uza.be.

UI	MeSH Term	Description	Entries
D011877	Radionuclide Imaging	The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph.	Gamma Camera Imaging,Radioisotope Scanning,Scanning, Radioisotope,Scintigraphy,Scintiphotography,Imaging, Gamma Camera,Imaging, Radionuclide
D001859	Bone Neoplasms	Tumors or cancer located in bone tissue or specific BONES.	Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D058990	Molecular Targeted Therapy	Treatments with drugs which interact with or block synthesis of specific cellular components characteristic of the individual's disease in order to stop or interrupt the specific biochemical dysfunction involved in progression of the disease.	Targeted Molecular Therapy,Molecular Targeted Therapies,Molecular Therapy, Targeted,Targeted Molecular Therapies,Targeted Therapy, Molecular,Therapy, Molecular Targeted,Therapy, Targeted Molecular

Related Publications

Tim Van den Wyngaert, and Frédéric Paycha

Targeted radionuclide therapy for bone metastases.

January 1993, European journal of nuclear medicine,

Tim Van den Wyngaert, and Frédéric Paycha

Bone-Targeted Imaging and Radionuclide Therapy in Prostate Cancer.

October 2016, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,

Tim Van den Wyngaert, and Frédéric Paycha

Quantitative imaging of 223Ra-chloride (Alpharadin) for targeted alpha-emitting radionuclide therapy of bone metastases.

July 2012, Nuclear medicine communications,

Tim Van den Wyngaert, and Frédéric Paycha

Radionuclide Therapy of Bone Metastases.

April 2012, Breast care (Basel, Switzerland),

Tim Van den Wyngaert, and Frédéric Paycha

Quantitative radionuclide imaging of bone metastases.

June 2019, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...,

Tim Van den Wyngaert, and Frédéric Paycha

Advances in radionuclide imaging for bone metastases.

April 2003, Ortopedia, traumatologia, rehabilitacja,

Tim Van den Wyngaert, and Frédéric Paycha

[Radionuclide therapy for painful bone metastases].

January 2004, Wiadomosci lekarskie (Warsaw, Poland : 1960),

Tim Van den Wyngaert, and Frédéric Paycha

Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting (223)Ra-dichloride.

January 2016, European journal of nuclear medicine and molecular imaging,

Tim Van den Wyngaert, and Frédéric Paycha

Prognostic Factors of Bone Metastases From Colorectal Cancer in the Era of Targeted Therapy.

March 2023, Diseases of the colon and rectum,